Gland Pharma Allots 3,739 Equity Shares to Employees Under ESOP Scheme
Total issued share capital increases to Rs. 16,50,14,593 with shares issued at exercise prices of Rs. 773.30 and Rs. 1 per share on November 16, 2026
Gland Pharma Limited allotted 3,739 equity shares to 2 employees on November 16, 2026, under its Employee Stock Option Scheme 2025, increasing its total issued share capital to Rs. 16,50,14,593 comprising 165,014,593 equity shares of Rs.1 each. This issuance reflects ongoing employee stock benefits in compliance with SEBI regulations.
Gland Pharma Limited
Corporate Action
Gland Pharma Limited allotted 3,739 equity shares to two employees upon exercise of stock options under its Employee Stock Option Scheme 2025, raising its total issued share capital to Rs. 16,50,14,593 as of November 16, 2026.
The equity shares allotted have a face value of Re. 1 each and are fully paid-up, issued pursuant to the exercise of employee stock options.
Of the shares allotted, 2,474 shares were issued at an exercise price of Rs. 773.30 each and 1,265 shares at Rs. 1 each, as defined under the company's ESOP 2025 scheme.
Following this allotment, the total number of equity shares stands at 165,014,593, maintaining parity with existing shares, with a total issued share capital of Rs. 16,50,14,593.
The shares were allotted on November 16, 2026, and no lock-in period applies to these newly issued shares.
The company's shares are listed on the BSE and the National Stock Exchange of India under the tickers 543245 and GLAND respectively.
Highlights
- 3,739 equity shares allotted on November 16, 2026 to 2 employees under ESOP Scheme 2025.
- Issued shares increased to 165,014,593 with total share capital of Rs. 16,50,14,593.
- Exercise prices were Rs. 773.30 per share for 2,474 shares and Rs. 1 per share for 1,265 shares.
- Shares issued rank pari passu with existing shares and have no lock-in period.
- Shares listed on BSE (Scrip Code: 543245) and NSE (Symbol: GLAND).
Key Data Snapshot
What happened
- Gland Pharma allotted 3,739 fully paid equity shares to two employees exercising stock options.
- Shares were issued under the Gland Pharma Employee Stock Option Scheme 2025.
- The issuance took place on November 16, 2026, increasing the company's total issued share capital.
Key details
- 2,474 shares were allotted at an exercise price of Rs. 773.30 per share and 1,265 shares at Rs. 1 per share.
- The company’s issued share capital increased to Rs. 16,50,14,593, comprising 165,014,593 equity shares.
- All allotted shares rank equally with existing equity shares and there is no lock-in period applicable.
Regulatory and governance context
- The allotment complies with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
- Company has filed required disclosures with both BSE and NSE as per regulatory obligations.
Highlights
- 3,739 equity shares allotted on November 16, 2026 to 2 employees under ESOP Scheme 2025.
- Issued shares increased to 165,014,593 with total share capital of Rs. 16,50,14,593.
- Exercise prices were Rs. 773.30 per share for 2,474 shares and Rs. 1 per share for 1,265 shares.
- Shares issued rank pari passu with existing shares and have no lock-in period.
- Shares listed on BSE (Scrip Code: 543245) and NSE (Symbol: GLAND).
Disclosures
- SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
More News on Corporate Action
View allLatest corporate announcements and market updates in Corporate Action.
Kothari Industrial Corporation Proposes to Double Borrowing Limit to ₹1,000 Crore with Shareholder Vote via Postal Ballot
Kothari Industrial Corporation Limited has notified shareholders of a proposed special resolution to increase its borrowing limit from ₹500 crore to ₹1,000 crore and to authorize creating mortgages or charges on company properties as security. The company has initiated a postal ballot process with electronic voting from November 18 to December 17, 2026.
Read Full StoryBosch Home Comfort India Names Sangeetha Chhajed as Independent Director, Approves INR 400 Crore Related Party Deal
Bosch Home Comfort India Limited plans to appoint Mrs. Sangeetha Chhajed as an Independent Director with a term from October 1, 2026 to September 30, 2031. The company also seeks shareholder approval for material related party transactions with Highly Electrical Appliances India Pvt. Ltd., setting a financial limit of INR 400 crores per financial year until the 2027 Annual General Meeting.
Read Full StoryGland Pharma Grants 85,317 Employee Stock Options to Two Employees Under ESOP 2025
Gland Pharma Limited's ESOP Compensation Committee approved granting 85,317 employee stock options to two employees under the ESOP 2025 scheme, with a detailed vesting schedule and pricing formula.
Read Full Story